Group Metacognitive Therapy for Severe Antidepressant and CBT Resistant Depression: A Baseline-Controlled Trial
- 1.5k Downloads
A significant proportion of individuals experience treatment-resistant depression, defined as a lack of or limited response to current recommended treatments. This study evaluated the effectiveness of group metacognitive therapy (GMCT) for patients who had not responded to both antidepressants and cognitive-behaviour therapy. Following a no-treatment baseline monitoring period, ten patients received 12 2-h weekly sessions, two post-treatment booster sessions and were followed up at 6 months. All of the patients completed GMCT, suggesting that this treatment was acceptable. GMCT was associated with significant improvements across measures of depression, anxiety, rumination, and positive and negative metacognitive beliefs about rumination. These gains were maintained at follow-up. Analyses of rates of recovery revealed that 70 % of patients were classified as recovered and a further 20 % as improved at both post-treatment and 6 months follow-up. There were also reductions in the frequency of comorbid diagnoses. This preliminary study supports further research into GMCT for treatment-resistant depression as a potential clinical and cost effective intervention.
KeywordsTreatment-resistant depression Antidepressant Cognitive-behaviour therapy Metacognitive therapy Group therapy
Conflict of Interest
Costas Papageorgiou and Adrian Wells declare that they have no conflict of interest.
All procedures followed were in accordance with the ethical standard of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2000 (5). Informed consent was obtained from all patients for being included in the study.
No animal studies were carried out by the authors for this article.
- American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders (4th ed.). Washington, DC: Author.Google Scholar
- American Psychological Association (1993). Task force on promotion and dissemination of psychological procedures. A report to the Division 12 Board of the American Psychological Association.Google Scholar
- Dammen, T., Papageorgiou, C., & Wells, A. (in press). An open trial of group metacognitive therapy for depression in Norway. Nordic Journal of Psychiatry.Google Scholar
- Dimidjian, S., Hollon, S. D., Dobson, K. S., Schmaling, K. B., Kohlenberg, R. J., Addis, M. E., et al. (2006). Randomized trial of behavioral activation, cognitive therapy and antidepressant medication in the acute treatment of adults with major depression. Journal of Consulting and Clinical Psychology, 74, 658–670.PubMedCrossRefGoogle Scholar
- First, M. B., Spitzer, R. L., Gibbon, M., & Williams, J. B. W. (1997). Structured clinical interview for DSM-IV axis I disorders—Patient edition (SCID-I/P). New York: Biometrics Research Department, New York State Psychiatric Institute.Google Scholar
- Frank, E., Prien, R. F., Jarrett, R. B., Keller, M. B., Kupfer, D. J., Lavori, P. W., et al. (1991). Conceptualization and rationale for consensus definitions of terms in major depressive disorder: Remission, recovery, relapse and recurrence. Archives of General Psychiatry, 48, 851–855.PubMedCrossRefGoogle Scholar
- Keller, M. B., McCullough, J. P., Klein, D. N., Arnow, B., Dunner, D. L., Gelenberg, A. J., et al. (2000). A comparison of nefazodone, the cognitive-behavioral analysis system of psychotherapy, and their combination for the treatment of chronic depression. New England Journal of Medicine, 342, 1462–1470.PubMedCrossRefGoogle Scholar
- Lyubomirsky, S., & Tkach, C. (2004). The consequences of dysphoric rumination. In C. Papageorgiou & A. Wells (Eds.), Depressive rumination: Nature, theory and treatment (pp. 21–41). Chichester: Wiley.Google Scholar
- National Institute for Health and Clinical Excellence. (2004). Depression: Management of depression in primary and secondary care. National Clinical Practice Guideline Number, 23.Google Scholar
- Papageorgiou, C. (2009). Cognitive behaviour therapy, depressive rumination and metacognition. In G. Simos (Ed.), Cognitive behaviour therapy: A guide for the practising clinician (pp. 18–33). East Sussex: Routledge.Google Scholar
- Papageorgiou, C., & Wells, A. (2004). Nature, functions, and beliefs about depressive rumination. In C. Papageorgiou & A. Wells (Eds.), Depressive rumination: Nature, theory and treatment (pp. 3–20). Chichester: Wiley.Google Scholar
- Papageorgiou, C., Wells, A., & Meina, L. J. (in preparation). Development and preliminary validation of the Negative Beliefs about Rumination Scale.Google Scholar
- Roth, A., & Fonagy, P. (1996). What works for whom? A critical review of psychotherapy research. New York: Guilford Press.Google Scholar
- Trivedi, M. H., Rush, A. J., Wisniewski, S. R., Nierenberg, A. A., Warden, D., Ritz, L., et al. (2006). Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: Implications for clinical practice. American Journal of Psychiatry, 163, 28–40.PubMedCrossRefGoogle Scholar
- Wells, A. (2009). Metacognitive therapy for anxiety and depression. New York: Guilford Press.Google Scholar
- Wells, A., & Matthews, G. (1994). Attention and emotion: A clinical perspective. Hove: Erlbaum.Google Scholar
- Wells, A., & Papageorgiou, C. (2004). Metacognitive therapy for depressive rumination. In C. Papageorgiou & A. Wells (Eds.), Depressive rumination: Nature, theory and treatment (pp. 259–273). Chichester: Wiley.Google Scholar